Rchr
J-GLOBAL ID：201801003100661150   Update date: Oct. 02, 2024

Ishida Hiroaki

イシダ ヒロアキ | Ishida Hiroaki
Research theme for competitive and other funds  (4)：
  • 2024 - 2027 Development of turn-on type fluorescent labeling molecules oriented toward regulation of nuclear receptor activity
  • 2024 - 2025 Research on creation of novel dual-functional molecules using ethynyl sulfonamide structures
  • 2024 - 2025 Research on the synthesis of trisubstituted oxazole using hypervalent iodine and its application to the treatment of type 2 diabetes
  • 2021 - 2024 Design and synthesis of Vitamin D analogues for reduction of hypercalcemia.
Papers (16)：
  • Tetsuya Yano, Takahiro Yamada, Hiroaki Isida, Nami Ohashi, Toshimasa Itoh. 2-cyanopyridine derivatives enable N-terminal cysteine bioconjugation and peptide bond cleavage of glutathione under aqueous and mild conditions. RSC Advances. 2024
  • Hiroyuki Kojima, Ryota Yanagi, Eri Higuchi, Mami Yoshizawa, Tomoyuki Shimodaira, Misaki Kumagai, Tatsuhiro Kyoya, Miyu Sekine, Daichi Egawa, Nami Ohashi, et al. Covalent Modifier Discovery Using Hydrogen/Deuterium Exchange-Mass Spectrometry. Journal of Medicinal Chemistry. 2023. 66. 7. 4827-4839
  • Miyu Sekine, Hiroaki Ishida, Toshimasa Itoh. Synthesis of Triazolo[c]coumarins and Differences in the Fluorescence Properties of Their Isomers. Asian Journal of Organic Chemistry. 2023. 12. 5. e202300013
  • Mami Takyo, Yumi Sato, Naoya Hirata, Keisuke Tsuchiya, Hiroaki Ishida, Takashi Kurohara, Yuta Yanase, Takahito Ito, Yasunari Kanda, Keiko Yamamoto, et al. Oligoarginine-Conjugated Peptide Foldamers Inhibiting Vitamin D Receptor-Mediated Transcription. ACS Omega. 2022. 7. 50. 46573-46582
  • Hiroaki Ishida, Shoya Homma, Ryota Kasuga, Keiko Yamamoto, Toshimasa Itoh. Synthesis of Tetrahydrofuro[2,3-<i>d</i>]oxazoles and Oxazoles by Hypervalent Iodine (III)-Promoted [2 + 2 + 1] Annulation. Chemical and Pharmaceutical Bulletin. 2022. 70. 3. 192-194
ｍore...
MISC (2)：
  • 田京茉実, 田京茉実, 三澤隆史, 平田尚也, 諫田泰成, 石田寛明, 山本恵子, 出水庸介, 出水庸介. Development of helical peptides containing non-proteinogenic amino acids inhibiting VDR-mediated transcription. 日本薬学会年会要旨集(Web). 2022. 142年会. 27T-pm21
  • 田京茉実, 田京茉実, 三澤隆史, 黒原崇, 石田寛明, 山本恵子, 出水庸介, 出水庸介. ビタミンD受容体転写阻害ペプチドの創製. 日本薬学会関東支部大会講演要旨集. 2021. 65th
Patents (1)：
  • SYNUCLEINOPATHY THERAPEUTIC MEDICATION
Lectures and oral presentations  (16)：
  • Design and synthesis of the vitamin D receptor ligand containing three-membered heterocycles.
    (The 140th Annual Meeting of the Pharmaceutical Society of Japan 2020)
  • 新規フロオキサゾール合成法の適用拡大とPPAR リガンド創製への展開
    (第45回反応と合成の進歩シンポジウム 2019)
  • 新規furooxazole合成法を適用したPPARリガンドの開発研究
    (日本薬学会第139年会 2019)
  • 核内受容体を標的とした非共有結合型不可逆リガンドの開発
    (レチノイド研究会 第29回学術集会 2018)
  • 学生実習メディシナルケミストリー(3年)の導入
    (日本薬学会第138年会 2018)
ｍore...
Education (3)：
  • 2012 - 2015 Chiba University
  • 2010 - 2012 Chiba University
  • 2006 - 2010 Chiba University Faculty of Pharmaceutical Sciences
Professional career (1)：
  • 博士(薬科学) (千葉大学)
Work history (3)：
  • 2022/04 - 現在 Showa Pharmaceutical University Laboratory of Drug Design and Medicinal Chemistry Senior Assistant Professor
  • 2017/04 - 2022/03 Showa Pharmaceutical University
  • 2015/04 - 2017/03 Showa Pharmaceutical University
Committee career (1)：
  • 2018/05 - 現在 次世代を担う有機化学シンポジウム 世話人
Association Membership(s) (9)：
The Society of Iodine Science ,  Japanese Society for Retinoid Research ,  THE VITAMIN SOCIETY OF JAPAN ,  THE SOCIETY OF SYNTHETIC ORGANIC CHEMISTRY, JAPAN ,  THE PHARMACEUTICAL SOCIETY OF JAPAN ,  Japanese Society for Chemical Biology ,  The Japanese Society for Artificial Intelligence ,  日本アカデミック・ディテーリング研究会 ,  International Society of Heterocyclic Chemistry
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM